NVNO
enVVeno Medical Corp
NASDAQ · Healthcare · Medical - Devices · US
$7.02
+4.08%Oct 2, 2026, 12:44 UTC
enVVeno Medical Corporation announced it will present its investigational enVVe System at The VEINS 2026 innovation summit in Las Vegas, Nevada.
Source:Aug 21, 2026, 20:38 UTC
ENVVENO MEDICAL CORP filed a mixed shelf registration statement to offer up to $100 million in securities.
Source:Aug 4, 2026, 12:46 UTC
enVVeno Medical highlighted the publication of a peer-reviewed health economic study in the Journal of Vascular Surgery: Venous and Lymphatic Disorders demonstrating the cost-effectiveness of its enVVe replacement venous valve therapy versus standard of care for deep venous chronic venous insufficiency.
Source:Jul 31, 2026, 12:30 UTC
enVVeno Medical received FDA IDE approval to begin the TAVVE pivotal trial for its enVVe System, a first-in-class minimally invasive replacement venous valve.
Source:Jul 7, 2026, 12:29 UTC
enVVeno Medical Corporation announced the issuance of U.S. Patent No. 12,575,932 for its enVVe transcatheter replacement venous valve system.
Source: